The commercial lawsuit filed before the Dammam Commercial Court between Al Mouwasat Medical Services Company and Doctors Medical Projects Company puts the Saudi business and financial community to an important legal test, at the intersection of company law, the regulations governing the capital market, and the principles of contractual obligation.

The case concerns a claim by Doctors Medical Projects Company seeking to compel Al Mouwasat to purchase its entire 32.42% stake in Jeddah Doctors Company for a precisely specified amount of SAR 335,384,900.

Al Mouwasat, for its part, has limited its response to denying that it signed any final sale contract or agreement, confirming that its operational and financial position remains stable and that there is no need to make any financial provisions at this time.

This divergence has sparked a wide-ranging debate that goes beyond the mere fact that a lawsuit has been filed, addressing the depth of the relationship between the shareholders and the limits of transparency owed to all shareholders.

Transparency and Protecting the Company’s Position in Court

In an initial assessment of the case, Noura Al-Juraid @Noura Saad raised questions about the timing and accuracy of disclosure. She noted that details of correspondence or the background to the valuation leaking to the press before being clarified in the company’s official disclosures on Tadawul could undermine shareholder confidence in the company. She also asked whether the size of the claim itself calls for a higher level of transparency.

The claimant, @مريم العليمي, distinguished between two scenarios involving prior correspondence:

  • If it consisted merely of preliminary, non-binding discussions, the company would not be required to disclose them, as they created no contractual obligation.
  • If, however, it included material commitments that explain how the dispute arose, it would be preferable to disclose their nature to the extent necessary to clarify the risks for shareholders, without prejudicing the company’s legal position.

The claimant, @مريم العليمي, also supported her position with provisions from the Capital Market Authority’s Rules on the Offer of Securities and Continuing Obligations—specifically, Article 65, which requires immediate disclosure of disputes valued at 5% or more of the company’s net assets, and Article 63, which requires disclosures to be clear and accurate. She noted that the issue here is that the claim relies on implied valuations that were never formally set out in a final contract.

Legal Analysis: Breaking Down the Facts and Possible Outcomes

Legally, attention is focused on two decisive issues:

  • Balancing disclosure with judicial caution: The company met the minimum legal requirement by announcing the claim amount and shareholding percentage as a material event. Its reluctance to publish details of the negotiations reflects a reasonable desire to avoid any implied admission that could weaken its defense in court.
  • Proving an obligation at the pre-contractual stage: The burden of proof falls on the claimant, who must establish whether the correspondence gave rise to liability for advanced negotiations that created legitimate expectations, or whether the shareholders’ agreement contains binding provisions permitting a mandatory exit despite the absence of a final sale contract.

The debate is not over yet...

Where do you stand between those who believe the absence of a signed contract resolves the dispute in the company’s favor and rules out any obligation, and those who believe that preliminary correspondence and share valuations give rise to contractual liability that cannot be ignored?

Do you agree that disclosure should be limited to denying the existence of a written agreement in order to protect the company’s position in court, or do you believe that the size of the claim requires the company to disclose details of its prior negotiations to shareholders?

Share your views and legal comments on this issue. We also welcome your contributions to the other aspects of the case.